1 / 7

Exploring Direct-to-Consumer Drug Marketing Ethics: Insights from Raymond Gilmartin

This article delves into the ethical implications of direct-to-consumer marketing strategies for pharmaceuticals. Featuring an insightful interview with Raymond Gilmartin, former CEO of Merck, we discuss the responsibilities of companies in promoting drugs transparently while maintaining consumer safety. We also explore the FDA's regulatory role and highlight concerns about unregulated industries like herbal supplements, exemplified by companies like GNC and highlights from the "Dirty Dozen" herbs list.

aldis
Télécharger la présentation

Exploring Direct-to-Consumer Drug Marketing Ethics: Insights from Raymond Gilmartin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ethics March 2nd

  2. Direct to consumer marketing of drugs • Interview with Raymond Gilmartin (Merck) • FAQ • Update

  3. Life isn’t fair • Harrison Bergeron

  4. The FDA • A Dirty Dozen

  5. Herbs • A large unregulated industry • GNC • Height Max • Avacor • Herbal Watch

  6. 1984 Law

More Related